Magnetic susceptibility as a promising marker for predicting future severity of Parkinson’s disease

FHS
July 18, 2023
12:20 pm

Researchers evaluate quantitative magnetic susceptibility mapping in detecting quantifiable markers of Parkinson’s disease progression.

EpiBiologics names Ann Lee-Karlon as CEO and president

Ann Lee-Karlon will build the company’s pipeline of bispecific antibody protein degrader therapeutics. Photo: EpiBiologics / Business Wire. Biotechnology company EpiBiologics has appointed Dr Ann Lee-Karlon as

July 21, 2023

Stem cell therapy trial shows promise for regenerative treatment of heart failure

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical

December 13, 2023

Unveiling the role of EBV in the onset and progression of multiple sclerosis

Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international research team is now

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.